Biotech Profile

Latest News and Resources

Biotech Profile

Oxford-Harrington Rare Disease Centre – $250 Million Committed to Advance 40 Therapies into Clinical Trials by 2034

21 January 2026

Biotech Profile

Ocugen – Targeting 300,000 RP Patients with Gene-Agnostic Modifier Therapy Platform

4 November 2025

Biotech Profile

Kindling Bio – Creating One Scalable Gene Therapy to Flag Multiple Childhood Tumors for Immune Destruction

31 October 2025

Biotech Profile

Hemispherian – First-in-Class TET2 Agonist Tackles Glioblastoma Through DNA Demethylation

22 October 2025

Biotech Profile

Citius Pharmaceuticals – From Late-Stage Development to Commercial Launch with FDA-Approved LYMPHIR™

10 October 2025

Biotech Profile

VERIGRAFT – First Industrially Scalable Personalised Tissue Therapy Platform Advances to Pivotal Phase II

12 September 2025

Biotech Profile

GeoVax – From HIV Vaccine Pioneer to Multi-Platform Developer Targeting 40 Million Immunocompromised Americans

5 September 2025

Biotech Profile

Ciloa – First to Overcome 30-Year Challenge of Stable, Functional Recombinant Adiponectin Production

6 August 2025

Biotech Profile

One Biosciences – First clinical-grade single-cell transcriptomic platform for FFPE samples targets tumor heterogeneity gap

4 August 2025

Biotech Profile

Priothera – From Novartis Shelved Asset to Phase 3 in Five Years

4 August 2025